Neutropenia

• FDA approval · 2006-10-25
  FDA Approved: NEUPOGEN — Supplemental Application (Amgen, Inc)

  FDA approved a supplemental application for NEUPOGEN (filgrastim) submitted by Amgen, Inc. The action relates to the approval of changes in …

• FDA approval · 2006-10-25
  FDA Approved: NEULASTA — Supplemental Application (Amgen, Inc)

  The FDA approved a supplemental application for NEULASTA (pegfilgrastim) submitted by Amgen.